Betmiga

Betmiga Description

mirabegron

Manufacturer:

Distributor:

Zuellig Pharma

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Description

Each prolonged-release tablet contains 50 mg of mirabegron.
Excipients/Inactive Ingredients: Core tablet: Macrogols, Hydroxypropylcellulose, Butylhydroxytoluene, Magnesium stearate.
Film coating: Hypromellose, Macrogol, Iron oxide yellow.

Continue with Google

Already a member? Sign In

Betmiga Description

mirabegron

Manufacturer:

Astellas Pharma

Distributor:

Zuellig Pharma